2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
151
Gastrointestinal
73
Genitourinary
44
Other hematologic neoplasm
37
Thoracic
34
Lymphoid
33
Other
28
Tumor-Agnostic
18
Gynecologic
18
Head & Neck
12
Plasma cell
11
CNS
10
Endocrine
5
Dermatologic
5
Sarcoma
2
Other solid neoplasm
2
Myeloid
2
Other neoplasm
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
1
Cytopenia
1
Interventions
Cyclophosphamide
94
fludarabine phosphate
87
Busulfan
64
Cyclosporine
57
Epoetin Alfa
55
Peripheral Blood Stem Cell Transplantation
54
Mycophenolic Acid
54
Whole-Body Irradiation
53
fludarabine
45
Antilymphocyte Serum
43
Filgrastim
41
Cytarabine
41
Melphalan
40
Tacrolimus
39
Darbepoetin alfa
39
Methotrexate
34
Radiotherapy
33
Cord Blood Stem Cell Transplantation
28
Granulocyte Colony-Stimulating Factor
23
apixaban
22
Methylprednisolone
22
Rivaroxaban
21
Etoposide
21
Thiotepa
17
Dalteparin
17
eltrombopag
16
ferric carboxymaltose
14
epoetin beta
14
Daunorubicin
14
Azacitidine
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Exercise
×
Classical hematology
×
Clear all
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled